• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血小板第4因子的肝素可动员池:静脉注射与皮下注射肝素及卡比肝素片段2165的比较

The heparin-mobilisable pool of platelet factor 4: a comparison of intravenous and subcutaneous heparin and Kabi heparin fragment 2165.

作者信息

O'Brien J R, Etherington M D, Pashley M A

出版信息

Thromb Haemost. 1985 Dec 17;54(4):735-8.

PMID:4089807
Abstract

Some clinical advantages are claimed for low molecular weight heparin so the mobilisation of platelet factor 4 (PF 4) from the endothelial pool by the heparins may be relevant. Unfractionated (UF) heparin has been compared with Kabi heparin fragment 2165. A single intravenous (i.v.) injection of 60 iu/kg heparin was compared with 5000 anti-Xa units of Kabi-2165. Less PF 4 was mobilised by Kabi-2165 and some apparently remained in the pool and was released when the pool was subsequently challenged by giving i.v. heparin. Subcutaneous (s.c.) injections of 5000 iu heparin twice daily were compared with 5000 anti-Xa units of Kabi-2165 once daily, each given for a week. The plasma PF 4 was never raised yet when finally challenged with i.v. heparin the pool was "empty" or refractory after the s.c. heparin but some PF 4 remained after the s.c. Kabi-2165. The two glycosaminoglycans (GAGs) had widely differing half-lives but the t/2 of the PF 4 mobilised by the two GAGs was similar even though the PF 4 is apparently bound to the GAG.

摘要

低分子量肝素具有一些临床优势,因此肝素从内皮细胞池动员血小板因子4(PF 4)可能与之相关。已将普通肝素(UF)与卡比肝素片段2165进行了比较。将60 iu/kg肝素的单次静脉注射与5000抗Xa单位的卡比-2165进行比较。卡比-2165动员的PF 4较少,一些显然仍留在池中,当随后通过静脉注射肝素刺激该池时会被释放。将每日两次皮下注射5000 iu肝素与每日一次皮下注射5000抗Xa单位的卡比-2165进行比较,每种给药一周。皮下注射肝素后血浆PF 4从未升高,但最终用静脉注射肝素刺激时,皮下注射肝素后该池“空了”或不应答,而皮下注射卡比-2165后仍有一些PF 4残留。这两种糖胺聚糖(GAGs)的半衰期差异很大,但两种GAGs动员的PF 4的t/2相似,尽管PF 4显然与GAG结合。

相似文献

1
The heparin-mobilisable pool of platelet factor 4: a comparison of intravenous and subcutaneous heparin and Kabi heparin fragment 2165.血小板第4因子的肝素可动员池:静脉注射与皮下注射肝素及卡比肝素片段2165的比较
Thromb Haemost. 1985 Dec 17;54(4):735-8.
2
Low molecular weight heparin (KABI 2165) as thromboprophylaxis in elective visceral surgery. A randomized, double-blind study versus unfractionated heparin.低分子量肝素(KABI 2165)用于择期内脏手术的血栓预防。一项与普通肝素对比的随机双盲研究。
Thromb Haemost. 1986 Dec 15;56(3):243-6.
3
Haemodialysis with low MW heparin: dosage requirements for the elimination of extracorporeal fibrin formation.低分子量肝素血液透析:消除体外纤维蛋白形成的剂量要求。
Nephrol Dial Transplant. 1986;1(3):179-87.
4
Comparison of subcutaneous unfractionated heparin with a low molecular weight heparin (Fragmin) in patients with venous thromboembolism and contraindications to coumarin.
Thromb Haemost. 1994 Jan;71(1):7-11.
5
Low molecular weight heparin and the heparin mobilisable pool of platelet factor 4 are reduced in young survivors of myocardial infarction.低分子量肝素和血小板因子4的肝素可动员池在心肌梗死年轻幸存者中减少。
Thromb Res. 1996 Mar 15;81(6):615-22. doi: 10.1016/0049-3848(96)00037-0.
6
Effects of standard heparin and a low molecular weight heparin (Kabi 2165) on fibrinolysis.标准肝素和低分子量肝素(卡比2165)对纤维蛋白溶解的作用。
Thromb Haemost. 1988 Oct 31;60(2):311-3.
7
[Pharmacokinetics of heparin after a single intravenous or subcutaneous injection].单次静脉注射或皮下注射后肝素的药代动力学
Schweiz Med Wochenschr. 1977 Jun 11;107(23):810-5.
8
Comparison of two treatment durations (6 days and 14 days) of a low molecular weight heparin with a 6-day treatment of unfractionated heparin in the initial management of unstable angina or non-Q wave myocardial infarction: FRAX.I.S. (FRAxiparine in Ischaemic Syndrome).低分子量肝素两种治疗疗程(6天和14天)与普通肝素6天疗程在不稳定型心绞痛或非Q波心肌梗死初始治疗中的比较:FRAX.I.S.(缺血综合征中的速碧林)。
Eur Heart J. 1999 Nov;20(21):1553-62. doi: 10.1053/euhj.1999.1879.
9
Pharmacokinetics and pharmacodynamics of a low molecular weight heparin (enoxaparin) after subcutaneous injection, comparison with unfractionated heparin--a three way cross over study in human volunteers.低分子量肝素(依诺肝素)皮下注射后的药代动力学和药效学,与普通肝素的比较——一项在人类志愿者中的三交叉研究
Thromb Haemost. 1994 Mar;71(3):305-13.
10
Intravascular release and urinary excretion of tissue factor pathway inhibitor during heparin treatment.肝素治疗期间组织因子途径抑制物的血管内释放及尿排泄
J Lab Clin Med. 2004 Nov;144(5):246-53; discussion 226-7. doi: 10.1016/j.lab.2004.08.001.

引用本文的文献

1
Heparin Induced Thrombocytopenia for the Perioperative and Critical Care Clinician.围手术期及重症监护临床医生的肝素诱导性血小板减少症
Curr Anesthesiol Rep. 2020;10(4):501-511. doi: 10.1007/s40140-020-00405-6. Epub 2020 Aug 29.
2
Dalteparin: an update of its pharmacological properties and clinical efficacy in the prophylaxis and treatment of thromboembolic disease.达肝素:其在预防和治疗血栓栓塞性疾病方面的药理特性及临床疗效的最新进展
Drugs. 2000 Jul;60(1):203-37. doi: 10.2165/00003495-200060010-00010.
3
Dalteparin sodium. A review of its pharmacology and clinical use in the prevention and treatment of thromboembolic disorders.
达肝素钠。其药理学及在预防和治疗血栓栓塞性疾病中的临床应用综述。
Drugs. 1996 Aug;52(2):276-305. doi: 10.2165/00003495-199652020-00011.